The GLP is committed to full transparency. Download and review our 2019 Annual Report

Viewpoint: Do male doctors tend to be paternalistic when treating ‘female’ diseases?

| | October 15, 2018
Doreen Carvajal. Image credit: Claire Zeggane
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

When my silent assassin emerged last autumn, I pressed my surgeon about the prognosis for a form of peritoneal cancer that strikes women in stealthy fashion.

“Do you really want to know?” he replied. “Your cancer is incurable.”

How were these paternalistic doctors so confident about their edicts for women? It gave me solace to challenge them with questions. After an eternity in the journalism business, it was all I knew how to do. What about alternative treatments at other hospitals? New medical techniques? Fresh hope? But clearly it annoyed my doctors.

[A]t last, a woman took command of my care as the leader of an ovarian cancer research project. This oncologist listened to my questions. She explained medical approaches. She promised me that her goal was a cure instead of surrender. And she was the very first to propose immunotherapy, which harnesses the patient’s own immune system to attack cancer.

Related article:  Viewpoint: Activists push glyphosate cancer scare as proxy to limit use of genetically engineered crops

With the addition of immunotherapy, over the weeks my CA125 count started plunging dramatically to a normal count of four.

Some days I gasp involuntarily for air, savoring this new hope. Today, 10 months after my symptoms first appeared, I am cancer free.

Read full, original post: Male doctors said my ‘female’ cancer was incurable. Then a woman took command and gave me hope

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend